Antibody Scientist - BD/Platform Licensing

A unique opportunity for Antibody Discovery Scientists to transition into a commercial role focusing on out licensing cutting edge platforms on behalf of a global CRO/Biotech based in Boston.

Please note the role will be onsite in Boston with local travel 25%

No previous experience is required as training is provided but most show ability to communicate complex science to multiple stakeholders and strong understanding of early discovery workflows!

The Role

• Identify and develop external business opportunities across out-licensing, co-development and other strategic transactions .


• Lead the development and presentation of compelling business cases for prioritized external opportunities , providing robust analysis of key assumptions, risks and internal/external considerations.


• Independently initiate, develop and present external opportunities to senior management.


• Lead cross-functional due diligence and alliance management , working closely with R&D, CMC, Clinical, Regulatory, Operations and Finance teams, while providing executive-level reporting and acting as the primary BD contact where required.


• Manage BD activities throughout the transaction lifecycle, including proposals, term sheet development, negotiations, deal execution and ongoing alliance management .


• Contribute to the development and evolution of the organisation's business development and licensing strategy , ensuring alignment with broader corporate and portfolio objectives.


• Represent the organisation at industry, investor and partnering conferences , building and maintaining relationships across the pharmaceutical and biotechnology sectors.

Requirements

• Ph.D. in Pharmacology, Immunology, Cancer Biology or a related biomedical science discipline.


• Strong background in antibody drug discovery , with a deep understanding of target validation and hit-to-lead optimisation.


• Ability to interpret complex biological data, including affinity, specificity and in vivo efficacy , and translate scientific findings into compelling therapeutic and licensing narratives.


• Strong understanding of modern antibody modalities, including monoclonal antibodies, bispecific antibodies and ADCs .


• Excellent strategic and commercial thinking , with the ability to connect internal scientific capabilities with pharmaceutical and biotechnology partner needs.


• Strong communication, presentation and stakeholder-management skills, with the ability to work effectively across scientific, commercial and executive audiences.